Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis
Description | |
Date de publication | |
Auteurs | Santinon F, Batignes M, Mebrek ML, Biton JM, Clavel G, Herve R, Lemeiter D, Breckler M, Busato F, Tost J, Ziol M, Boissier MC, Decker P, Semerano L and Bessis N |
Revue | |
Année | 2,020 |
Département / Service | |
Laboratoire | |
Impact Factor | |
Institut | JACOB |
url DOI | 10.1002/art.41134 |